208 E7777 (denileukin diftitox) enhances anti-tumor activity and significantly extends survival benefit of anti-PD-1 in syngeneic solid tumor models

• Mary Woodall-Jappe,
• A Raghav Chari,
• Anil Namboodiripad,
• Chandrasekhar Goda

Affiliations

Mary Woodall-Jappe

Aff1 grid.418767.bEisai Inc. Andover MA USA

A Raghav Chari

2Dr. Reddy’s Laboratories, Princeton, NJ, USA

Anil Namboodiripad

2Dr. Reddy’s Laboratories, Princeton, NJ, USA

Chandrasekhar Goda

2Dr. Reddy’s Laboratories, Princeton, NJ, USA